High level dialogue event on clinical urgent needs and facilitation of rare disease drug imports held in Beijing

At the beginning of the year, the "Shunyi Tour of Multinational Pharmaceutical Companies - High level Dialogue on Facilitating the Import of Rare Disease Drugs in Urgent Clinical Needs" was successfully held at the Capital International Convention Center located in Shunyi District, Beijing. The event brings together various forces such as government departments, medical institutions, and multinational pharmaceutical companies, aiming to optimize the import path of urgently needed clinical and rare disease drugs, discuss new facilitation measures, and inject new momentum into improving drug accessibility and enhancing people's well-being.

At the scene, relevant leaders from the Beijing Municipal Health Commission, Beijing Drug Administration, Beijing Medical Insurance Bureau, Beijing Customs, Shunyi District Government, Capital International Airport Airport Management Committee and other members of the joint working mechanism of the Beijing Rare Disease Drug Guarantee Pilot Zone, as well as the Chairman of the China Rare Disease Alliance, representatives of white list import enterprises from Science Park Trading, 12 medical institutions including Beijing Children's Hospital, Friendship Hospital, and Peking University Third Hospital, experts and scholars, and more than 50 domestic and foreign pharmaceutical enterprise leaders gathered together. The guests engaged in in-depth dialogue on core issues such as urgent clinical needs and rare disease drug imports, innovative facilitation of pharmaceutical trade ports, and policy empowerment for the pharmaceutical and health industry, and jointly drew a blueprint for cooperation.

The policy interpretation and practical experience sharing session was exciting and diverse. The Beijing Food and Drug Administration, Beijing Municipal Health Commission, Beijing Children's Hospital, and Science Park Trading have conducted authoritative interpretations and practical sharing on "rare disease and clinically urgent drug imports" from various dimensions such as drug declaration, expert evaluation, and pharmaceutical service models, promoting collaboration between multinational pharmaceutical companies and government departments to enhance drug accessibility and affordability; The Beijing Municipal Medical Insurance Bureau, Beijing Tianzhu Customs, and Beijing Municipal Bureau of Commerce respectively introduced 32 new measures to support the high-quality development of innovative drugs in Beijing, as well as measures to facilitate customs clearance at Tianzhu Port and policies to support foreign investment and headquarters enterprises. Shunyi District also released policies to support the pharmaceutical and health industry, showcasing Beijing's "Beijing wisdom" and "Beijing speed" in accelerating market access and creating a first-class business environment, further sending a strong signal of Beijing's high-quality development of the pharmaceutical industry and sharing the Chinese market.

The Tianzhu Comprehensive Bonded Zone Management Committee, as a promoter and builder of the rare disease drug guarantee pilot zone, actively collaborates with municipal regulatory departments to innovate and promote the implementation of the Beijing model of 'whitelist system, bonded stocking, phased exit, and full traceability', opening up a green channel for clinical use of drugs that have been listed abroad and are urgently needed domestically. In the next step, we will continue to deepen the construction of the pilot zone, promote the import of clinical urgently needed and rare disease drugs, ensure long-term medication for patients, establish and improve the linkage service mechanism of drug and equipment innovation, and promote the development of the entire industrial chain. "said the relevant person in charge of the Capital Airport Economic Zone Management Committee.

The attendees believed that the "Shunyi Tour of Multinational Pharmaceutical Enterprises" has established an international platform for government enterprise dialogue, medical enterprise docking, cross-border cooperation, and ecological links, promoting the comprehensive release of policy dividends. During the forum interactive session, topics such as urgently needed clinical drug supply and access, policy advantages of pilot zones, and continuous innovation sparked heated discussions.

The policy of the rare disease drug guarantee pilot zone is extremely breakthrough, which has opened up a fast track for the introduction of rare disease drugs urgently needed in clinical practice, realizing the transformation from 'people waiting for drugs' to' drugs waiting for people ', allowing rare disease patients in China to simultaneously benefit from international cutting-edge innovative drugs, and also providing an example for rare disease drug guarantee in China, "said Li Xingang, Deputy Director of the Pharmacy Department of Beijing Friendship Hospital.

It is reported that Shunyi District has currently listed the pharmaceutical and health industry as a key development industry. Through a series of measures such as policy coordination, accelerated customs clearance, bonded innovation, and the construction of pilot zones, the industry has been promoted and achieved positive results. By 2025, the overall industrial scale will reach 69.1 billion yuan, with an average annual growth rate of 17.4% for three consecutive years. Especially, relying on the shipping advantage of connecting 225 destinations in 57 countries around the world through the Capital International Airport, the pharmaceutical trade is leading in the country. The pharmaceutical trade volume in Tianzhu Comprehensive Bonded Zone has exceeded 100 billion yuan for three consecutive years, accounting for nearly one-third of the country's total. Tianzhu Port has become the largest pharmaceutical trade port in China, with a stable core hub position.

The release of the first special support policy for the pharmaceutical and health industry in Shunyi District will further strengthen the district's hub position in the field of pharmaceutical trade, attract multinational pharmaceutical companies to layout research and development, distribution, and supply chain businesses in the Capital Airport Economic Zone, and help promote the development of a billion dollar pharmaceutical trade industry cluster, "said the relevant person in charge of the Tianzhu Comprehensive Bonded Zone Management Committee.